AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

Agenus has reported deep tumour responses and no observed colorectal [...]

NICE has recommended glycopyrronium bromide cream as an option for [...]

Remepy has raised $36M in a Series A financing round [...]

Zilucoplan has been accepted for restricted use in NHS Scotland [...]

The FDA has issued a Complete Response Letter for ITM-11, [...]

Adneuris Therapeutics has granted Maruishi Pharmaceutical exclusive rights to develop [...]

AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]

AB2 Bio will receive $30 million from Nippon Shinyaku after [...]

PolyPid’s D-PLEX100 has been granted FDA Priority Review following acceptance [...]